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ABSTRACT 
 
Background: Cervical cancer screening was introduced in 2013 mid-year at Ndola Central Hospital. Although 
cervical cancer is the second most common cancer among women worldwide, it is the commonest cancer in 
developing countries where it is closely associated with women of low-to-middle socioeconomic status. Cervical 
cancer screening results using VIA can either be negative or positive. Methods: The research was a retrospective 
study conducted at Ndola Central Hospital, Ndola, Zambia. Patient enrolment registers were retrospectively 
analyzed and 3,433 records were reviewed within the study period 2014-2015.Data was collected as; total enrolled, 
VIA-DC results, cryotherapy, biopsy and Loop Electrosurgical Excisional Procedure (LEEP). Data analysis was 
done using SPSS. Results: A total of 3,433 women were screened, 11.3% were VIA-DC-positive out of which, 
26.3% were eligible for cryotherapy, 45.4% were scheduled for LEEP, and 20.4% were suspicious for ICC and were 
referred for biopsy. Over 80% of women screened were in the age group 25-45 years which contributed a big 
number of VIA-DC-positive screen (58.2%). However, 38.0% women who were referred for biopsy were in the 
group 40-50years.The overall HIV prevalence in the study was 17.2%.Conclusion: The high rateof VIA-DC-
positive screens are suggestive of a high rate of plausible cervical cancer cases later in life. This therefore indicates 
the need for expansion of cervical cancer screening and prevention programmes throughout the nation. There is also 
need for increased community sensitization on cervical cancer prevention and adequate treatment of cervical pre-
cancerous lesions. 
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Introduction 
The outcomes of cervical cancer screening helps 
determine the burden of cervical cancer. The burden of 
cervical cancer in developed countries is low compared 
to developing countries where it constitutes a major 
public health problem worldwide. Cervical cancer is 
the second most common cancer among women 
worldwide and it is the commonest cancer in women 
with low-to-middle socioeconomic status in developing 
countries [1][2].In 2012, over 520,000 new cases of 
cervical cancer were diagnosed worldwide and about 
266 000death, 85% mortality occurred in less  
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developed regions [3].The number of new cases from 
2000 to 2012 had increased although surprisingly 
developed countries recorded a reduction in the number 
of new cases diagnosed. This shows that the burden of 
cervical cancer is increasing in developing countries 
and therefore, the conclusion is that cervical cancer is 
closely associated with low-to-medium socioeconomic 
status [2][4].Africa, especially Sub-Saharan Africa has 
a high incidence of cervical cancer cases reported at 
rates exceeding 50 per 100,000 population and the age-
standardized mortality were exceeding 40 per 100,000. 
The disease is the most common cause of cancer death 
among women in the region [5].Zambia has been 
ranked second in the top 25 countries with highest 
incidence rates, with an incidence of 1,839 cases per 
year, estimated to be 52.8% on an age-adjusted 
incidence, making cervical cancer the most common 
cancer among women. The increased number of new 
cases and death observed in Zambia may be attributed 
to lack of screening, inadequate treatment of 
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precancerous lesions, women shunning away from 
cervical cancer screening and inability to either initiate 
or sustain cervical cancer prevention programmes 
[4][6]. According to a research conducted in six 
African countries, 1,381 women were screened in 
Zambia out of which 386 (28.0%)had a VIA-positive 
screen. In the same study, 1,221 women were screened 
in Malawi and only 151 (12.4%) had a VIA-positive 
screen result and 5,529 women screened in Nigeria out 
of which 317 (5.7%) had a VIA-positive screen 
result[7] [8].This suggests that cervical cancer is a 
major public health problem in Zambia and there is 
need to scale-up interventions aimed at preventing and 
treating precancerous lesions in order to reduce the 
increased prevalence and mortality rates. Visual 
Inspection with Acetic acid (VIA)is a screening 
technique that involves performing a vaginal speculum 
examination. Dilute acetic acid (3-5%) is applied on 
the cervix and visualised with the naked eyes and with 
the aid of a high-resolution digital camera (digital 
cervicography) to capture a photo for a clearer and 
magnified view of the cervix.The combination of 
naked eye view and digital camera aided view is called 
VIA-Digital cervicography (VIA-DC). Cervical lesions 
are identified as an opaque blight white well defined 
area on the cervix described as “acetowhite” (dull or 
oyster white lesion)most often located at the 
squamocolumnar junction as a sharply demarcated, 
distinct and well-defined dense lesion from adjacent 
normal epithelium. VIA-DC results can either be 
negative if no acetowhite lesions seen or positive testan 
acetowhite lesion is seen on the cervix. VIA-DC can 
done along with cryotherapy either in the form of a 
“single visit” approach or in the form of a “see and 
treat” approach. The combination of VIA-DC and 
cryotherapy in a single visit approach offers secondary 
prevention of cervical cancer and can be carried out by 
a competent physicians or non-physicians health care 
giver, including nurses and midwives at the screening 
centre. VIA-DC-positive result may requires antibiotic 
therapy, cryotherapy Loop Electrosurgical Excision 
Procedure (LEEP) or referral for biopsy depending on 
the extent of the acetowhite lesion. Treatment services 
for advanced disease should be readily accessible by 
the patient and offered according to the adopted 
national protocol, and set guidelines for management 
of cervical cancer [8][10].The purpose of this research 
was to assess and compare the outcomes of cervical 
cancer screening for the year 2014 and 2015 so as to 
ascertain the status of the cervical cancer prevention 
programme at Ndola Central Hospital. Zambia has very 
little information concerning cervical cancer 
prevalence and mortality rates which may be attributed 
to little research being done on cervical cancer at both 
hospital and national level [9]. In spite of the Zambian 
government’s efforts to address the issue of cervical 
cancer by introduction of cervical cancer prevention 
programmes in many provinces, there is still need to 
know the previous and current status of the prevalence 
of cervical cancer VIA-DC-positive screen. There was 
need therefore for this research to determine the 
outcome of cervical cancer screening. The project will 
help evaluate the status of cervical cancer screening at 
Ndola Central Hospital, and determine the appropriate 
recommendations with regard to cervical cancer 
screening and its related programmes. 
Objectives 
 To determine the total number of women 
screened for cervical cancer at NCH for the 
period 2014-2015. 
 To determine the prevalence of VIA-DC-positive 
screen for the period 2014-2015. 
 To assess the Age-VIA positive correlation. 
 
Materials and methods 
 
Study site and Ethical considerations 
The study was conducted at Ndola Central Hospital, in 
Ndola, Copperbelt province, Zambia. It is a third level 
hospital which started offering cervical cancer 
screening mid-year in 2013. Ethical clearance was 
obtained fromTropical Disease Research Centre 
(TDRC) ethics committee. Permission to conduct the 
research wasgranted by Ndola Central Hospital 
management. 
Sample population, Sample size and Inclusion criteria 
 
The research was done retrospectively by systematic 
review of cervical cancer screening registers. The 
registers had all the information required for the data 
collection, but also has records pertaining women who 
came for reviews. New enrolments (women on their 
first visit) and women who came for review were 
entered in the same register but only distinguished by 
the type of ink colour used when recording the data. 
New enrolments were written in blue ink and red ink 
was used for those who came for reviews. The sample 
included all new enrolments between 2014 and 
2015and all women who came for reviews were 
excluded from the data collection. The study period for 
the research was from 1
st
 January 2014 to 31
st
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December 2015 and the research was conducted from 
8
th
May to 21
st
 June 2016,  that is data collection. 
Data collection, Entry and Analysis 
During data collection, the information of interest was; 
age, HIV status, screen results and intervention. From 
2014 to 2015, 3,433 records were reviewed. Data 
collection went as follows; firstly a total of new 
enrolments were counted and recorded, then all VIA-
DC-positives and VIA-DC-negatives, followed by 
cases eligible for cryotherapy, Loop Electrosurgical 
Excision Procedure (LEEP) and Biopsy. HIV positive 
and HIV negatives were also recorded. This was 
repeated for each month until all data for all 24 month. 
The second part involved grouping VIA-DC results 
into age-groups of 5 years starting with less than 20 
years. This involved identifying the VIA-DC-positive 
and VIA-DC-negative results then checking their 
corresponding age. The collected data was entered in 
Microsoft® Excel database for storage and was later 
exported to Statistical Package for Social Sciences 
(SPSS) version 16for analysis. Data analysis involved 
generation of tables, frequencies and charts. 
Results 
 
A total of 3,433 women were screened for cervical 
cancer, 2,153 in 2014 and 1,280 in 2015.From the total 
number of women screened, 388 (11.3%) were VIA-
DC-positive and 3045 (88.7%) women were VIA-DC-
negative. Of the 388 VIA-DC-positive cases, 26.3% 
were eligible for cryotherapy, 45.4% were scheduled 
for LEEP, and 20.4% were suspicious for invasive 
cervical cancer (ICC) and were referred for biopsy. The 
remaining 8.0% did not meet the criteria for 
cryotherapy and thus were treated with antibiotics. 
Figure 1 show a flow chart with the summary of results 
obtained for the study period. 
 
 
 
 
Fig 1: Summary of final results obtained from the study 
 
Table 1 shows individual results for 2014 and 2015 
Table 1:  Number of women according to the intervention for each year 
 
YEAR VIA-DC-positive CRYOTHERAPY LEEP BIOPSY Others* 
2014 275 73 134 51 17 
2015 113 29 42 28 14 
Total 388 102 176 79 31 
*Treated with antibiotic 
Total number of 
cases 
n= 3,433  
VIA-DC-
Negative 
n= 3,045 (88.7%) 
VIA-DC-Positive 
n=388 (11.3%) 
Not eligible for 
cryotherapy 
n= 31 (8.0%) 
Eligible for 
Cryotherapy 
n= 102 (26.3%) 
Eligible for 
LEEP 
n= 176 (45.4%) 
Suspecious for 
ICC 
n= 79 (20.4%) 
Referral 
for Biopsy 
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Table 2: VIA-positive screen rates by year 
 
YEAR Number Screened VIA Positive 
n= (%) 
2014 2,153 275(12.8%) 
2015 1,280 113(8.8%) 
Total 3,433 388(11.3%) 
 
Table 2 shows the prevalence of VIA-DC-positive screen for 2014 and 2015 and the overall prevalence. From table 
3, 112 VIA-DC-positive women were in the age group 20-29 and 118 were in the age group 30-39 and 6 girls below 
20 years had a positive screen result. However, the majority of women with suspected ICC were in the age group 
40-50years (38% of all referral for biopsy). 
 
Table 3: Age for VIA positive 
 
AGE VIA positive BIOPSY 
<20 6 0 
20-29 112 6 
30-39 118 15 
40-50 80 30 
>50 11 26 
 
A total of 33 women had VIA-DC-positive screen whose age was not recorded and only 2 women referred for 
biopsy had their age not recorded. Of all the women screened, 591 were HIV positive, 2,405 were negative and 437 
didn’t know their HIV status. The prevalence of HIV in the study population was 17.2%. Women whose HIV status 
was unknown were 12.7%, these were offered Diagnostic Counselling and Testing (DCT) to which they have the 
mandate to decline. Figure 2 shows that the majority of women screened were from the age group 25-45 accounting 
for over 75% of all women screened and this representing 58.2% of all VIA-DC-positive cases. 
 
 
 
Fig 2: Final results obtained from the study 
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Fig 3: VIA-positive results in relation to Age-groups 
Discussion 
 
Ndola Central Hospital is one of the few Hospitals in 
the Copperbelt that offers cervical cancer screening 
services using VIA-DC enhanced. All the statistical 
information in this report is centred on the data 
collected based on the information compiled at Ndola 
Central Hospital cervical cancer prevention clinic for 
the period 204-2015.From 2014 to 2015, a total of 
3,433 women attended the cervical cancer prevention 
clinic and were screened for cervical cancer. The 
overall prevalence of VIA-DC-positive screen for the 
study period was 11.3%. 2014 represents the majority 
of VIA-positive case with a rate of approximately 71% 
of the total VIA-DC-positive results, with only about 
29% for 2015. The intervention offered to women with 
VIA-positive women was based on the percentage of 
the cervix involved as follows: antibiotic therapy for 
lesions suggestive of inflammation; cryotherapy for 
lesions limited to the cervical os;LEEP for lesions 
involving more than 75% of the cervix and referral for 
biopsy for lesions suggestive of ICC (for example 
contact bleeding).Out of the total VIA-DC-positive 
cases, 20.4% were referred for biopsy representing 
2.3% of the total number of women screened between 
2014 and 2015. The aforementioned percentage 
represents women who presented late and had lesions 
suggestive of ICC requiring biopsy for confirmation 
and as a guidance for management. Such a high rate of 
11.3% VIA-DC-positive cases suggest significant 
likelihood of high prevalence of potential cervical 
cancer cases in future, implying the need for continued 
cervical cancer screening and same day treatment with 
cryotherapy. Although the VIA-DC-positive 
prevalence(11.3%)is high, it is consistent with findings 
in many studies and has been found to be lower than 
the rate recorded in a study conducted in Lusaka (1,381 
women were screened and 386 (28.0%) were VIA-
positive) as part of the research done in six African 
countries by WHO [8].Although WHO recommends 
prioritizing screening the target age-group 35-45, the 
study has shown that there was a considerable number 
of VIA-positive case of women less than 35 years, 
representing 4.5% (40.2% of all VIA-positive women) 
of the total number of women screened. Thus screening 
of women younger than 35 years will be beneficial 
especially with the availability of same day treatment 
with cryotherapy. The age range of women enrolled 
and screened was from 16 years to older than 70 years, 
but the majority of women screened were aged 
between 25 and 45. This actually shows a wider 
coverage of the women at risk and will help reduce 
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women’s chances of developing cervical cancer later in 
life as it can be detected at a much earlier stage at 
which treatment can be cheap, optimal and less 
invasive. This age range entails that there is no age 
restriction for screening and thus gives an equal 
opportunity to all women to be screened and live a 
health life. From table 3 above, the majority of women 
with a VIA-positive screen result were aged between 
20 and 29 but the number was close to that of women 
in the aged between 30 and 39 although patients as 
young as 18 years were observed. On the other hand, 
the age range for women referred for biopsy was above 
25 years with a peak age between 40 and 50 years 
representing 38.0% all women referred for biopsy, this 
shows that every woman has a higher chance of 
cervical cancer free life if screened at or before 35 
years than when the screen is performed after 45 years. 
In essence, cervical cancer screening is critical and 
most important to a woman aged between 30 and 45 
years. These findings are consistence with other studies 
and also with WHO recommendations for the cervical 
cancer screening target age group of 35-45 years in 
resource limited settings where only one screen per 
woman can be done[2].The high rate of  VIA-positive 
screen results observed in the age group 20-29 years 
can be explained based on the fact that this age group 
correspond with the period closest to women’s sexual 
debut and a period at which women’s sexual activity 
are high. This is concurrent with a period at which 
HPV infection is acquired, owing to changes seen on 
the cervical Another important observation of note that 
can help strengthen the above explanation is that only 6 
women were preferred for biopsy within the same age 
group. This then explains the fact that most of the 
visualised lesion in the age group 20-29 years were 
highly unlikely to be pre-cancerous.There is need for 
further research to assess the utilization of same day 
cryotherapy treatment and to determine barriers that 
may impede access to screening services including 
treatment and cost of sustaining screening programmes. 
Due to the differences in the results obtained in 2014 
and 2015, there is need for intensified awareness of 
cervical cancer to the community though Information, 
Education and Communication (IEC) to increase the 
number of women accessing cervical cancer screening. 
Emphasis is being put on strengthening cervical cancer 
related research at hospital level so as to get further 
insight of the burden of cervical cancer which in turn 
will help in strategic planning of programmes that are 
aimed at reducing the burden of cervical cancer among 
women at national level.The burden ofcervical cancer 
not only affects the health and lives of women, but also 
their children, families, and the community at large as 
women are critical to social and economic stability of 
the country and hence need for continued cervical 
cancer screening programmes to avert the burden. 
 
Conclusion 
 
High rates of VIA-DC-positive screens recorded from 
the study suggest a significant burden of cervical 
cancer and also entails that there is an impending high 
rate of potential cervical cancer cases later in life. This 
therefore is a plausible indication for the need to 
expand cervical cancer screening and prevention 
programmes throughout the nation if cervical cancer 
rates are to be reduced. In addition to this, community 
sensitization on cervical cancer prevention, recognition 
of symptoms and the importance of screening will 
enable the success of implemented cervical cancer 
prevention programmes. 
 
Recommendations 
 
 More research is needed to determine the 
knowledge of cervical cancer screening among 
women in the risk age group and also to 
determine the prevalence of cervical cancer 
confirmed by biopsy results. 
 There is need for acquisition of proper register 
books that are durable for record keeping. 
 Proper maintenance and backup of available 
electronic storage system for cervical cancer 
records needs to be consistent and strengthened. 
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